Pacific Biosciences Of California (PACB) EBIT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 48.29% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 23.33% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 14.49% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -1.59% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 411.30% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -5.84% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 0.58% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -164.91% |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 0.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.54% |
| Mar 31, 2026 | 98.05% |
| Dec 31, 2025 | 73.08% |
| Sep 30, 2025 | 39.33% |
| Jun 30, 2025 | 74.49% |
| Mar 31, 2025 | -427.19% |
| Dec 31, 2024 | -74.79% |
| Sep 30, 2024 | 22.32% |
| Jun 30, 2024 | -140.31% |
| Mar 31, 2024 | 10.84% |
| Dec 31, 2023 | -0.53% |
| Sep 30, 2023 | -10.55% |
| Jun 30, 2023 | -7.66% |
| Mar 31, 2023 | -17.71% |
| Dec 31, 2022 | -34.65% |
| Jun 30, 2022 | -80.90% |
| Mar 31, 2022 | -129.97% |
| Dec 31, 2021 | -169.74% |
| Jun 30, 2021 | -59.72% |
| Mar 31, 2021 | -3.06% |